Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | IMVT Immunovant, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $34.00 -1.6% | $15.23 -2.2% |
| StockIQ Score | 35F Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 20F | 13F |
| Fundamental | 46D+ | 35F |
| Growth | 32F | 50C- |
| Fair Value | 38F | 38F |
| News | 50C- | 50C- |
| Quality | — | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Immunovant (IMVT) scores higher in technical (25 vs. 18) and fundamental (46 vs. 35) metrics, suggesting stronger short-term price trends and core financial health. Ascentage Pharma (AAPG) leads in growth (50 vs. 32), indicating faster expansion potential. Both share equal investor scores (37) and valuation (38), leaving them tied in those areas.
